Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

SDHB (Succinate Dehydrogenase Complex Iron Sulfur Subunit B)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

SDHB deletion	Gastrointestinal Stromal Tumor	SDHB deletion	Gastrointestinal Stromal Tumor	regorafenib Sensitive: A2 - Guideline regorafenib Sensitive : A2	regorafenib Sensitive: A2 - Guideline regorafenib Sensitive : A2
SDHB deletion	Gastrointestinal Stromal Tumor	SDHB deletion	Gastrointestinal Stromal Tumor	binimetinib + YD312 Sensitive: A2 - Guideline binimetinib + YD312 Sensitive : A2	binimetinib + YD312 Sensitive: A2 - Guideline binimetinib + YD312 Sensitive : A2
SDHB deletion	Gastrointestinal Stromal Tumor	SDHB deletion	Gastrointestinal Stromal Tumor	pazopanib Sensitive: A2 - Guideline pazopanib Sensitive : A2	pazopanib Sensitive: A2 - Guideline pazopanib Sensitive : A2
SDHB deletion	Gastrointestinal Stromal Tumor	SDHB deletion	Gastrointestinal Stromal Tumor	sunitinib Sensitive: A2 - Guideline sunitinib Sensitive : A2	sunitinib Sensitive: A2 - Guideline sunitinib Sensitive : A2
SDHB mutation	Gastrointestinal Stromal Tumor	SDHB mutation	Gastrointestinal Stromal Tumor	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3
KIT wild-type + SDHB deletion	Gastrointestinal Stromal Tumor	KIT wild-type + SDHB deletion	Gastrointestinal Stromal Tumor	olverembatinib Sensitive: C3 – Early Trials olverembatinib Sensitive : C3	olverembatinib Sensitive: C3 – Early Trials olverembatinib Sensitive : C3
SDHB mutation + SDHD mutation	Neuroendocrine Tumor	SDHB mutation + SDHD mutation	Neuroendocrine Tumor	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
SDHB deletion	Gastrointestinal Stromal Tumor	SDHB deletion	Gastrointestinal Stromal Tumor	anlotinib Sensitive: C3 – Early Trials anlotinib Sensitive : C3	anlotinib Sensitive: C3 – Early Trials anlotinib Sensitive : C3
SDHB deletion	Gastrointestinal Stromal Tumor	SDHB deletion	Gastrointestinal Stromal Tumor	olverembatinib Sensitive: C3 – Early Trials olverembatinib Sensitive : C3	olverembatinib Sensitive: C3 – Early Trials olverembatinib Sensitive : C3
SDHB mutation	Pituitary Gland Carcinoma	SDHB mutation	Pituitary Gland Carcinoma	temozolomide Sensitive: C4 – Case Studies temozolomide Sensitive : C4	temozolomide Sensitive: C4 – Case Studies temozolomide Sensitive : C4
SDHB mutation + NF1 mutation	Gastrointestinal Stromal Tumor	SDHB mutation + NF1 mutation	Gastrointestinal Stromal Tumor	DS-6157 Sensitive: C4 – Case Studies DS-6157 Sensitive : C4	DS-6157 Sensitive: C4 – Case Studies DS-6157 Sensitive : C4